AshiBio
PrivateLast Round
Series A
Jun 20, 2024
Total Funding Raised
$40M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
AshiBio is a biotechnology company that develops innovative therapies aimed at preventing symptoms and slowing disease progression for patients with rare bone and connective tissue disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AshiBio Comparables
Compare AshiBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ipsen | 75% | |
| Mereo BioPharma Group plc | 72% | |
| SiSaf Ltd | 71% |
AshiBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 20, 2024 |
Key People
Founding team and executive leadership
AshiBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agent Capital | Series A |
| MPM BioImpact | Series A, Seed |
| Mirae Asset Venture Investment | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2026
Monthly visitors increased 32% MoM, reaching 2K.
- Jun 20, 2024
$40M round with participation from Mirae Asset and Agent Capital.
Recent news
Latest coverage and updates
- is_developingAug 19, 2026
Ashibio Inc is developing treatments for the condition. on Aug 19th '26.
AshiBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about AshiBio's valuation, stock price, and market status.
Is AshiBio a public or private company?
AshiBio is a private company.
What is the current stock price of AshiBio?
AshiBio is a private company with no public stock price. No recent secondary market data is available.
How much is AshiBio worth (valuation)?
Valuation information for AshiBio is not publicly available.
Can I buy AshiBio stock?
AshiBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was AshiBio's last funding round?
AshiBio's most recent funding round was Series A on June 20, 2024.
Who are the main investors in AshiBio?
Key investors in AshiBio include Agent Capital, Mirae Asset Venture Investment.
Will AshiBio IPO soon?
No public IPO plans have been announced for AshiBio.
How can I track AshiBio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AshiBio's secondary market activity and sign up for updates.